Clinical Trials Browser

OTHER × Oligometastatic Gastrointestinal Cancer × camrelizumab × Clear all

NCT04625894 2020-11-12

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Phase 1 Unknown

Gastrointestinal

Oligometastatic Gastrointestinal Cancer